Skip to main content
Top
Published in: BMC Cancer 1/2009

Open Access 01-12-2009 | Research article

Twist expression promotes migration and invasion in hepatocellular carcinoma

Authors: Noriyuki Matsuo, Hidenori Shiraha, Tatsuya Fujikawa, Nobuyuki Takaoka, Naoki Ueda, Shigetomi Tanaka, Shinichi Nishina, Yutaka Nakanishi, Masayuki Uemura, Akinobu Takaki, Shinichiro Nakamura, Yoshiyuki Kobayashi, Kazuhiro Nouso, Takahito Yagi, Kazuhide Yamamoto

Published in: BMC Cancer | Issue 1/2009

Login to get access

Abstract

Background

Twist, a transcription factor of the basic helix-loop-helix class, is reported to regulate cancer metastasis. It is known to induce epithelial-mesenchymal transition (EMT). In this study, we evaluated the expression of twist and its effect on cell migration in hepatocellular carcinoma (HCC).

Methods

We examined twist expression using immunohistochemistry in 20 tissue samples of hepatocellular carcinoma, and assessed twist expression in HCC cell lines by RT-PCR and Western blot analysis. Ectopic twist expression was created by introducing a twist construct in the twist-negative HCC cell lines. Endogenous twist expression was blocked by twist siRNA in the twist-positive HCC cell lines. We studied EMT related markers, E-cadherin, Vimentin, and N-cadherin by Western blot analysis. Cell proliferation was measured by MTT assay, and cell migration was measured by in vitro wound healing assay. We used immunofluorescent vinculin staining to visualize focal adhesion.

Results

We detected strong and intermediate twist expression in 7 of 20 tumor samples, and no significant twist expression was found in the tumor-free resection margins. In addition, we detected twist expression in HLE, HLF, and SK-Hep1 cells, but not in PLC/RPF/5, HepG2, and Huh7 cells. Ectopic twist-expressing cells demonstrated enhanced cell motility, but twist expression did not affect cell proliferation. Twist expression induced epithelial-mesenchymal transition together with related morphologic changes. Focal adhesion contact was reduced significantly in ectopic twist-expressing cells. Twist-siRNA-treated HLE, HLF, and SK-Hep1 cells demonstrated a reduction in cell migration by 50, 40 and 18%, respectively.

Conclusion

Twist induces migratory effect on hepatocellular carcinoma by causing epithelial-mesenchymal transition.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bosch FX, Ribes J, Borras J: Epidemiology of primary liver cancer. Seminars in liver disease. 1999, 19 (3): 271-285. 10.1055/s-2007-1007117.CrossRefPubMed Bosch FX, Ribes J, Borras J: Epidemiology of primary liver cancer. Seminars in liver disease. 1999, 19 (3): 271-285. 10.1055/s-2007-1007117.CrossRefPubMed
2.
go back to reference Okuda K: Hepatocellular carcinoma. Journal of hepatology. 2000, 32 (1 Suppl): 225-237. 10.1016/S0168-8278(00)80428-6.CrossRefPubMed Okuda K: Hepatocellular carcinoma. Journal of hepatology. 2000, 32 (1 Suppl): 225-237. 10.1016/S0168-8278(00)80428-6.CrossRefPubMed
3.
go back to reference Parkin DM, Pisani P, Ferlay J: Global cancer statistics. CA: a cancer journal for clinicians. 1999, 49 (1): 33-64. 10.3322/canjclin.49.1.33. Parkin DM, Pisani P, Ferlay J: Global cancer statistics. CA: a cancer journal for clinicians. 1999, 49 (1): 33-64. 10.3322/canjclin.49.1.33.
4.
go back to reference El-Serag HB, Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007, 132 (7): 2557-2576. 10.1053/j.gastro.2007.04.061.CrossRefPubMed El-Serag HB, Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007, 132 (7): 2557-2576. 10.1053/j.gastro.2007.04.061.CrossRefPubMed
5.
go back to reference El-Serag HB: Hepatocellular carcinoma: recent trends in the United States. Gastroenterology. 2004, 127 (5 Suppl 1): S27-34. 10.1053/j.gastro.2004.09.013.CrossRefPubMed El-Serag HB: Hepatocellular carcinoma: recent trends in the United States. Gastroenterology. 2004, 127 (5 Suppl 1): S27-34. 10.1053/j.gastro.2004.09.013.CrossRefPubMed
6.
go back to reference El-Serag HB, Mason AC: Rising incidence of hepatocellular carcinoma in the United States. The New England journal of medicine. 1999, 340 (10): 745-750. 10.1056/NEJM199903113401001.CrossRefPubMed El-Serag HB, Mason AC: Rising incidence of hepatocellular carcinoma in the United States. The New England journal of medicine. 1999, 340 (10): 745-750. 10.1056/NEJM199903113401001.CrossRefPubMed
7.
go back to reference De Giorgio M, Fagiuoli S: Management of hepatocellular carcinoma. Digestive diseases (Basel, Switzerland). 2007, 25 (3): 279-281.CrossRef De Giorgio M, Fagiuoli S: Management of hepatocellular carcinoma. Digestive diseases (Basel, Switzerland). 2007, 25 (3): 279-281.CrossRef
8.
go back to reference Kudo M, Okanoue T: Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Oncology. 2007, 72 (Suppl 1): 2-15. 10.1159/000111702.CrossRefPubMed Kudo M, Okanoue T: Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Oncology. 2007, 72 (Suppl 1): 2-15. 10.1159/000111702.CrossRefPubMed
9.
go back to reference Nakakura EK, Choti MA: Management of hepatocellular carcinoma. Oncology. 2000, 14 (7): 1085-1098.PubMed Nakakura EK, Choti MA: Management of hepatocellular carcinoma. Oncology. 2000, 14 (7): 1085-1098.PubMed
10.
go back to reference Eccles SA, Welch DR: Metastasis: recent discoveries and novel treatment strategies. Lancet. 2007, 369 (9574): 1742-1757. 10.1016/S0140-6736(07)60781-8.CrossRefPubMedPubMedCentral Eccles SA, Welch DR: Metastasis: recent discoveries and novel treatment strategies. Lancet. 2007, 369 (9574): 1742-1757. 10.1016/S0140-6736(07)60781-8.CrossRefPubMedPubMedCentral
11.
go back to reference Gilles C, Thompson EW: The epithelial to mesenchymal transition and metastatic progression in carcinoma. The Breast Journal. 1996, 2: 83-96. 10.1111/j.1524-4741.1996.tb00076.x.CrossRef Gilles C, Thompson EW: The epithelial to mesenchymal transition and metastatic progression in carcinoma. The Breast Journal. 1996, 2: 83-96. 10.1111/j.1524-4741.1996.tb00076.x.CrossRef
12.
13.
go back to reference Monk M, Holding C: Human embryonic genes re-expressed in cancer cells. Oncogene. 2001, 20 (56): 8085-8091. 10.1038/sj.onc.1205088.CrossRefPubMed Monk M, Holding C: Human embryonic genes re-expressed in cancer cells. Oncogene. 2001, 20 (56): 8085-8091. 10.1038/sj.onc.1205088.CrossRefPubMed
14.
go back to reference Thiery JP: Epithelial-mesenchymal transitions in development and pathologies. Current opinion in cell biology. 2003, 15 (6): 740-746. 10.1016/j.ceb.2003.10.006.CrossRefPubMed Thiery JP: Epithelial-mesenchymal transitions in development and pathologies. Current opinion in cell biology. 2003, 15 (6): 740-746. 10.1016/j.ceb.2003.10.006.CrossRefPubMed
15.
go back to reference Zajchowski DA, Bartholdi MF, Gong Y, Webster L, Liu HL, Munishkin A, Beauheim C, Harvey S, Ethier SP, Johnson PH: Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer research. 2001, 61 (13): 5168-5178.PubMed Zajchowski DA, Bartholdi MF, Gong Y, Webster L, Liu HL, Munishkin A, Beauheim C, Harvey S, Ethier SP, Johnson PH: Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer research. 2001, 61 (13): 5168-5178.PubMed
16.
go back to reference Bates RC, Mercurio AM: The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer biology & therapy. 2005, 4 (4): 365-370.CrossRef Bates RC, Mercurio AM: The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer biology & therapy. 2005, 4 (4): 365-370.CrossRef
17.
go back to reference Xue C, Plieth D, Venkov C, Xu C, Neilson EG: The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer research. 2003, 63 (12): 3386-3394.PubMed Xue C, Plieth D, Venkov C, Xu C, Neilson EG: The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer research. 2003, 63 (12): 3386-3394.PubMed
18.
go back to reference Thiery JP, Sleeman JP: Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 2006, 7 (2): 131-142. 10.1038/nrm1835.CrossRefPubMed Thiery JP, Sleeman JP: Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 2006, 7 (2): 131-142. 10.1038/nrm1835.CrossRefPubMed
19.
go back to reference Huber MA, Kraut N, Beug H: Molecular requirements for epithelial-mesenchymal transition during tumor progression. Current opinion in cell biology. 2005, 17 (5): 548-558. 10.1016/j.ceb.2005.08.001.CrossRefPubMed Huber MA, Kraut N, Beug H: Molecular requirements for epithelial-mesenchymal transition during tumor progression. Current opinion in cell biology. 2005, 17 (5): 548-558. 10.1016/j.ceb.2005.08.001.CrossRefPubMed
20.
go back to reference Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nature reviews. 2002, 2 (6): 442-454. 10.1038/nrc822.PubMed Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nature reviews. 2002, 2 (6): 442-454. 10.1038/nrc822.PubMed
21.
go back to reference Yook JI, Li XY, Ota I, Fearon ER, Weiss SJ: Wnt-dependent regulation of the E-cadherin repressor snail. The Journal of biological chemistry. 2005, 280 (12): 11740-11748. 10.1074/jbc.M413878200.CrossRefPubMed Yook JI, Li XY, Ota I, Fearon ER, Weiss SJ: Wnt-dependent regulation of the E-cadherin repressor snail. The Journal of biological chemistry. 2005, 280 (12): 11740-11748. 10.1074/jbc.M413878200.CrossRefPubMed
22.
go back to reference Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, Hung MC: Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nature cell biology. 2004, 6 (10): 931-940. 10.1038/ncb1173.CrossRefPubMed Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, Hung MC: Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nature cell biology. 2004, 6 (10): 931-940. 10.1038/ncb1173.CrossRefPubMed
23.
go back to reference Cheng GZ, Zhang W, Wang LH: Regulation of cancer cell survival, migration, and invasion by Twist: AKT2 comes to interplay. Cancer research. 2008, 68 (4): 957-960. 10.1158/0008-5472.CAN-07-5067.CrossRefPubMed Cheng GZ, Zhang W, Wang LH: Regulation of cancer cell survival, migration, and invasion by Twist: AKT2 comes to interplay. Cancer research. 2008, 68 (4): 957-960. 10.1158/0008-5472.CAN-07-5067.CrossRefPubMed
24.
go back to reference Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA: Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004, 117 (7): 927-939. 10.1016/j.cell.2004.06.006.CrossRefPubMed Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA: Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004, 117 (7): 927-939. 10.1016/j.cell.2004.06.006.CrossRefPubMed
25.
go back to reference Yang J, Mani SA, Weinberg RA: Exploring a new twist on tumor metastasis. Cancer research. 2006, 66 (9): 4549-4552. 10.1158/0008-5472.CAN-05-3850.CrossRefPubMed Yang J, Mani SA, Weinberg RA: Exploring a new twist on tumor metastasis. Cancer research. 2006, 66 (9): 4549-4552. 10.1158/0008-5472.CAN-05-3850.CrossRefPubMed
26.
go back to reference Lee TK, Poon RT, Yuen AP, Ling MT, Kwok WK, Wang XH, Wong YC, Guan XY, Man K, Chau KL, et al: Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res. 2006, 12 (18): 5369-5376. 10.1158/1078-0432.CCR-05-2722.CrossRefPubMed Lee TK, Poon RT, Yuen AP, Ling MT, Kwok WK, Wang XH, Wong YC, Guan XY, Man K, Chau KL, et al: Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res. 2006, 12 (18): 5369-5376. 10.1158/1078-0432.CCR-05-2722.CrossRefPubMed
27.
go back to reference Yang Z, Zhang X, Gang H, Li X, Li Z, Wang T, Han J, Luo T, Wen F, Wu X: Up-regulation of gastric cancer cell invasion by Twist is accompanied by N-cadherin and fibronectin expression. Biochemical and biophysical research communications. 2007, 358 (3): 925-930. 10.1016/j.bbrc.2007.05.023.CrossRefPubMed Yang Z, Zhang X, Gang H, Li X, Li Z, Wang T, Han J, Luo T, Wen F, Wu X: Up-regulation of gastric cancer cell invasion by Twist is accompanied by N-cadherin and fibronectin expression. Biochemical and biophysical research communications. 2007, 358 (3): 925-930. 10.1016/j.bbrc.2007.05.023.CrossRefPubMed
28.
go back to reference Ng IO, Chung LP, Tsang SW, Lam CL, Lai EC, Fan ST, Ng M: p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese. Oncogene. 1994, 9 (3): 985-990.PubMed Ng IO, Chung LP, Tsang SW, Lam CL, Lai EC, Fan ST, Ng M: p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese. Oncogene. 1994, 9 (3): 985-990.PubMed
29.
go back to reference Chen P, Gupta K, Wells A: Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis. J Cell Biol. 1994, 124 (4): 547-555. 10.1083/jcb.124.4.547.CrossRefPubMed Chen P, Gupta K, Wells A: Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis. J Cell Biol. 1994, 124 (4): 547-555. 10.1083/jcb.124.4.547.CrossRefPubMed
30.
go back to reference Raftopoulou M, Etienne-Manneville S, Self A, Nicholls S, Hall A: Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. Science (New York, NY). 2004, 303 (5661): 1179-1181.CrossRef Raftopoulou M, Etienne-Manneville S, Self A, Nicholls S, Hall A: Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. Science (New York, NY). 2004, 303 (5661): 1179-1181.CrossRef
31.
go back to reference Chen ZF, Behringer RR: twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes & development. 1995, 9 (6): 686-699. 10.1101/gad.9.6.686.CrossRef Chen ZF, Behringer RR: twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes & development. 1995, 9 (6): 686-699. 10.1101/gad.9.6.686.CrossRef
32.
go back to reference Lee MS, Lowe GN, Strong DD, Wergedal JE, Glackin CA: TWIST, a basic helix-loop-helix transcription factor, can regulate the human osteogenic lineage. Journal of cellular biochemistry. 1999, 75 (4): 566-577. 10.1002/(SICI)1097-4644(19991215)75:4<566::AID-JCB3>3.0.CO;2-0.CrossRefPubMed Lee MS, Lowe GN, Strong DD, Wergedal JE, Glackin CA: TWIST, a basic helix-loop-helix transcription factor, can regulate the human osteogenic lineage. Journal of cellular biochemistry. 1999, 75 (4): 566-577. 10.1002/(SICI)1097-4644(19991215)75:4<566::AID-JCB3>3.0.CO;2-0.CrossRefPubMed
33.
go back to reference Thisse B, el Messal M, Perrin-Schmitt F: The twist gene: isolation of a Drosophila zygotic gene necessary for the establishment of dorsoventral pattern. Nucleic acids research. 1987, 15 (8): 3439-3453. 10.1093/nar/15.8.3439.CrossRefPubMedPubMedCentral Thisse B, el Messal M, Perrin-Schmitt F: The twist gene: isolation of a Drosophila zygotic gene necessary for the establishment of dorsoventral pattern. Nucleic acids research. 1987, 15 (8): 3439-3453. 10.1093/nar/15.8.3439.CrossRefPubMedPubMedCentral
34.
go back to reference Vernon AE, LaBonne C: Tumor metastasis: a new twist on epithelial-mesenchymal transitions. Curr Biol. 2004, 14 (17): R719-721. 10.1016/j.cub.2004.08.048.CrossRefPubMed Vernon AE, LaBonne C: Tumor metastasis: a new twist on epithelial-mesenchymal transitions. Curr Biol. 2004, 14 (17): R719-721. 10.1016/j.cub.2004.08.048.CrossRefPubMed
35.
go back to reference Fackler MJ, McVeigh M, Evron E, Garrett E, Mehrotra J, Polyak K, Sukumar S, Argani P: DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma. International journal of cancer. 2003, 107 (6): 970-975. 10.1002/ijc.11508.CrossRefPubMed Fackler MJ, McVeigh M, Evron E, Garrett E, Mehrotra J, Polyak K, Sukumar S, Argani P: DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma. International journal of cancer. 2003, 107 (6): 970-975. 10.1002/ijc.11508.CrossRefPubMed
36.
go back to reference Rosivatz E, Becker I, Specht K, Fricke E, Luber B, Busch R, Hofler H, Becker KF: Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. The American journal of pathology. 2002, 161 (5): 1881-1891.CrossRefPubMedPubMedCentral Rosivatz E, Becker I, Specht K, Fricke E, Luber B, Busch R, Hofler H, Becker KF: Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. The American journal of pathology. 2002, 161 (5): 1881-1891.CrossRefPubMedPubMedCentral
37.
go back to reference Yuen HF, Chua CW, Chan YP, Wong YC, Wang X, Chan KW: Significance of TWIST and E-cadherin expression in the metastatic progression of prostatic cancer. Histopathology. 2007, 50 (5): 648-658. 10.1111/j.1365-2559.2007.02665.x.CrossRefPubMed Yuen HF, Chua CW, Chan YP, Wong YC, Wang X, Chan KW: Significance of TWIST and E-cadherin expression in the metastatic progression of prostatic cancer. Histopathology. 2007, 50 (5): 648-658. 10.1111/j.1365-2559.2007.02665.x.CrossRefPubMed
38.
go back to reference Alexander JJ, Bey EM, Geddes EW, Lecatsas G: Establishment of a continuously growing cell line from primary carcinoma of the liver. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 1976, 50 (54): 2124-2128.PubMed Alexander JJ, Bey EM, Geddes EW, Lecatsas G: Establishment of a continuously growing cell line from primary carcinoma of the liver. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 1976, 50 (54): 2124-2128.PubMed
39.
go back to reference Dor I, Namba M, Sato J: Establishment and some biological characteristics of human hepatoma cell lines. Gann = Gan. 1975, 66 (4): 385-392.PubMed Dor I, Namba M, Sato J: Establishment and some biological characteristics of human hepatoma cell lines. Gann = Gan. 1975, 66 (4): 385-392.PubMed
40.
go back to reference Knowles BB, Howe CC, Aden DP: Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science (New York, NY). 1980, 209 (4455): 497-499.CrossRef Knowles BB, Howe CC, Aden DP: Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science (New York, NY). 1980, 209 (4455): 497-499.CrossRef
41.
go back to reference Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J: Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer research. 1982, 42 (9): 3858-3863.PubMed Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J: Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer research. 1982, 42 (9): 3858-3863.PubMed
42.
go back to reference Turner BM, Turner VS: Secretion of alpha 1-antitrypsin by an established human hepatoma cell line and by human/mouse hybrids. Somatic cell genetics. 1980, 6 (1): 1-14. 10.1007/BF01538692.CrossRefPubMed Turner BM, Turner VS: Secretion of alpha 1-antitrypsin by an established human hepatoma cell line and by human/mouse hybrids. Somatic cell genetics. 1980, 6 (1): 1-14. 10.1007/BF01538692.CrossRefPubMed
43.
go back to reference Hendrix MJ, Seftor EA, Hess AR, Seftor RE: Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nature reviews. 2003, 3 (6): 411-421. 10.1038/nrc1092.PubMed Hendrix MJ, Seftor EA, Hess AR, Seftor RE: Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nature reviews. 2003, 3 (6): 411-421. 10.1038/nrc1092.PubMed
44.
go back to reference Ridley AJ, Hall A: The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell. 1992, 70 (3): 389-399. 10.1016/0092-8674(92)90163-7.CrossRefPubMed Ridley AJ, Hall A: The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell. 1992, 70 (3): 389-399. 10.1016/0092-8674(92)90163-7.CrossRefPubMed
45.
go back to reference Nobes CD, Hall A: Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell. 1995, 81 (1): 53-62. 10.1016/0092-8674(95)90370-4.CrossRefPubMed Nobes CD, Hall A: Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell. 1995, 81 (1): 53-62. 10.1016/0092-8674(95)90370-4.CrossRefPubMed
46.
go back to reference Kotani H, Takaishi K, Sasaki T, Takai Y: Rho regulates association of both the ERM family and vinculin with the plasma membrane in MDCK cells. Oncogene. 1997, 14 (14): 1705-1713. 10.1038/sj.onc.1200998.CrossRefPubMed Kotani H, Takaishi K, Sasaki T, Takai Y: Rho regulates association of both the ERM family and vinculin with the plasma membrane in MDCK cells. Oncogene. 1997, 14 (14): 1705-1713. 10.1038/sj.onc.1200998.CrossRefPubMed
Metadata
Title
Twist expression promotes migration and invasion in hepatocellular carcinoma
Authors
Noriyuki Matsuo
Hidenori Shiraha
Tatsuya Fujikawa
Nobuyuki Takaoka
Naoki Ueda
Shigetomi Tanaka
Shinichi Nishina
Yutaka Nakanishi
Masayuki Uemura
Akinobu Takaki
Shinichiro Nakamura
Yoshiyuki Kobayashi
Kazuhiro Nouso
Takahito Yagi
Kazuhide Yamamoto
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2009
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-9-240

Other articles of this Issue 1/2009

BMC Cancer 1/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine